Institute for Global Food Security, School of Biological Sciences, Queen's University, Belfast, UK.
Department of Biosciences, School of Science and Technology, Nottingham Trent University, Nottingham, UK.
J Med Microbiol. 2023 Nov;72(11). doi: 10.1099/jmm.0.001768.
is a Gram-negative anaerobe that is a member of the human gastrointestinal microbiota and is frequently found as an extra-intestinal opportunistic pathogen. comprises two distinct groups - divisions I and II - characterized by the presence/absence of genes [ and (), respectively] that confer resistance to β-lactam antibiotics by either serine or metallo-β-lactamase production. No large-scale analyses of publicly available sequence data have been undertaken, and the resistome of the species remains poorly defined. Reclassification of divisions I and II as two distinct species has been proposed but additional evidence is required.. To investigate the genomic diversity of GenBank genomes and establish the prevalence of division I and II strains among publicly available genomes, and to generate further evidence to demonstrate that division I and II strains represent distinct genomospecies.. High-quality (=377) genomes listed as in GenBank were included in pangenome and functional analyses. Genome data were also subject to resistome profiling using The Comprehensive Antibiotic Resistance Database. Average nucleotide identity and phylogenetic analyses showed divisions I and II represent distinct species: (=275 genomes) and A (=102 genomes; Genome Taxonomy Database designation), respectively. Exploration of the pangenome of and A revealed separation of the two species at the core and accessory gene levels.. The findings indicate that A, previously referred to as division II , is an individual species and distinct from . The pangenome analysis supported previous genomic, phylogenetic and resistome screening analyses collectively reinforcing that divisions I and II are two separate species. In addition, it was confirmed that differences in the accessory genes of divisions I and II are primarily associated with carbohydrate metabolism and suggest that differences other than antimicrobial resistance could also be used to distinguish between these two species.
是一种革兰氏阴性厌氧菌,是人类胃肠道微生物群的成员,经常作为肠道外机会性病原体存在。它由两个不同的群体组成——I 组和 II 组——其特征是分别存在/不存在赋予β-内酰胺抗生素抗性的基因 [和()],分别通过丝氨酸或金属β-内酰胺酶的产生。尚未对公开可用的序列数据进行大规模分析,该物种的耐药组仍然定义不明确。已经提出将 I 组和 II 组重新分类为两个不同的种,但需要更多的证据。......为了研究 GenBank 中基因组的多样性,确定 I 组和 II 组菌株在公开可用的基因组中的流行程度,并生成进一步的证据来证明 I 组和 II 组菌株代表不同的基因组种。......包括在 GenBank 中列为的高质量(=377)基因组被纳入泛基因组和功能分析。使用全面抗生素耐药数据库对基因组数据进行耐药组分析。平均核苷酸同一性和系统发育分析表明 I 组和 II 组代表不同的种:分别为(=275 个基因组)和(A=102 个基因组;基因组分类数据库指定)。对和 A 的泛基因组进行探索,发现这两个物种在核心和辅助基因水平上分离。......研究结果表明,以前称为 II 组的 A 是一个单独的物种,与不同。全基因组分析支持先前的基因组、系统发育和耐药组筛选分析,共同证明 I 组和 II 组是两个独立的种。此外,还证实 I 组和 II 组的辅助基因差异主要与碳水化合物代谢有关,这表明除了抗菌药物耐药性之外,还可以使用其他差异来区分这两个种。